Patient Capital Management’s Royalty Pharma RPRX Stock Holding History

Patient Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175M	Buy	3,643,716 +310,041	+9%	+$13.6M	6.52%	1
2025 Q4	$129M	Buy	3,333,675 +215,825	+7%	+$8.23M	4.97%	4
2025 Q3	$110M	Buy	3,117,850 +129,862	+4%	+$4.7M	4.4%	8
2025 Q2	$108M	Buy	2,987,988 +15,342	+0.5%	+$508K	4.86%	5
2025 Q1	$92.5M	Buy	2,972,646 +97,557	+3%	+$3.09M	4.76%	5
2024 Q4	$73.3M	Buy	2,875,089 +833,894	+41%	+$22.1M	3.38%	10
2024 Q3	$57.7M	Buy	2,041,195 +616,805	+43%	+$17.1M	2.84%	15
2024 Q2	$37.6M	Buy	1,424,390 +4,572	+0.3%	+$127K	1.99%	26
2024 Q1	$43.1M	Buy	1,419,818 +165,038	+13%	+$4.87M	2.1%	26
2023 Q4	$35.2M	Buy	+1,254,780	New	+$34.5M	1.87%	27

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return